The role of ESCO2, SALL4 and TBX5 genes in the susceptibility to thalidomide teratogenesis.
Ontology highlight
ABSTRACT: Thalidomide is widely used for several diseases; however, it causes malformations in embryos exposed during pregnancy. The complete understanding of the mechanisms by which thalidomide affects the embryo development has not yet been obtained. The phenotypic similarity makes TE a phenocopy of syndromes caused by mutations in ESCO2, SALL4 and TBX5 genes. Recently, SALL4 and TBX5 were demonstrated to be thalidomide targets. To understand if these genes act in the TE development, we sequenced them in 27 individuals with TE; we verified how thalidomide affect them in human pluripotent stem cells (hPSCs) through a differential gene expression (DGE) analysis from GSE63935; and we evaluated how these genes are functionally related through an interaction network analysis. We identified 8 variants i
SUBMITTER: Gomes JDA
PROVIDER: S-EPMC6684595 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA